207 related articles for article (PubMed ID: 35837176)
1. Decreased expression of claudin-18.2 in alpha-fetoprotein-producing gastric cancer compared to conventional gastric cancer.
Weng W; Zhang M; Ni S; Tan C; Xu M; Wang X; Sun H; Wang L; Huang D; Sheng W
J Gastrointest Oncol; 2022 Jun; 13(3):1035-1045. PubMed ID: 35837176
[TBL] [Abstract][Full Text] [Related]
2. The clinicopathological features and prognosis of serum AFP positive gastric cancer: a report of 16 cases.
Liu D; Li B; Yan B; Liu L; Jia Y; Wang Y; Ma X; Yang F
Int J Clin Exp Pathol; 2020; 13(9):2439-2446. PubMed ID: 33042357
[TBL] [Abstract][Full Text] [Related]
3. HER2 is frequently overexpressed in hepatoid adenocarcinoma and gastric carcinoma with enteroblastic differentiation: a comparison of 35 cases to 334 gastric carcinomas of other histological types.
Fujimoto M; Matsuzaki I; Nishino M; Iwahashi Y; Warigaya K; Kojima F; Ono K; Murata SI
J Clin Pathol; 2018 Jul; 71(7):600-607. PubMed ID: 29305518
[TBL] [Abstract][Full Text] [Related]
4.
Maruyama S; Furuya S; Shiraishi K; Shimizu H; Akaike H; Hosomura N; Kawaguchi Y; Amemiya H; Kawaida H; Sudo M; Inoue S; Kono H; Ichikawa D
World J Gastrointest Oncol; 2018 Oct; 10(10):344-350. PubMed ID: 30364858
[TBL] [Abstract][Full Text] [Related]
5. Re-evaluation of the prognosis of alpha-fetoprotein-producing gastric cancer from a single center: a case series study.
Akabane M; Yago A; Haruta S; Ohkura Y; Ueno M; Udagawa H
Langenbecks Arch Surg; 2023 Jan; 408(1):66. PubMed ID: 36695913
[TBL] [Abstract][Full Text] [Related]
6. The Relationship Between D-dimer and Prognosis in the Patients with Serum Alpha-Fetoprotein-Positive Gastric Cancer: A Retrospective Cohort Study.
Zhang X; Wang W; Tian B; Wang Y; Jing J
Clin Med Insights Oncol; 2022; 16():11795549221120158. PubMed ID: 36104997
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic and prognostic characteristics of alpha-fetoprotein-producing gastric cancer.
He R; Yang Q; Dong X; Wang Y; Zhang W; Shen L; Zhang Z
Oncotarget; 2017 Apr; 8(14):23817-23830. PubMed ID: 28423604
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and molecular characteristics of the alpha-fetoprotein-producing gastric cancer: emphasis on two major subtypes.
Lu J; Jin M; Zhou X; Chen X; Shao Y; Jiang X
APMIS; 2022 Mar; 130(3):169-180. PubMed ID: 34862662
[TBL] [Abstract][Full Text] [Related]
9. Treatment efficacy of ramucirumab-containing chemotherapy in patients with alpha-fetoprotein producing gastric cancer.
Kamiimabeppu D; Wakatsuki T; Takahari D; Fukuda N; Shimozaki K; Osumi H; Nakayama I; Ogura M; Ooki A; Shinozaki E; Chin K; Yamaguchi K
Int J Clin Oncol; 2023 Jan; 28(1):121-129. PubMed ID: 36409433
[TBL] [Abstract][Full Text] [Related]
10. Dynamic Change in Serum Alpha-fetoprotein Level Predicts Treatment Response and Prognosis of Alpha-fetoprotein-producing Gastric Cancer.
Wang R; Li J; Xu D; Li R; Gong P
Medicine (Baltimore); 2020 Nov; 99(47):e23326. PubMed ID: 33217870
[TBL] [Abstract][Full Text] [Related]
11. Significant response to ramucirumab monotherapy in chemotherapy-resistant recurrent alpha-fetoprotein-producing gastric cancer: A case report.
Arakawa Y; Tamura M; Aiba K; Morikawa K; Aizawa D; Ikegami M; Yuda M; Nishikawa K
Oncol Lett; 2017 Sep; 14(3):3039-3042. PubMed ID: 28928842
[TBL] [Abstract][Full Text] [Related]
12. Single-cell characteristics and malignancy regulation of alpha-fetoprotein-producing gastric cancer.
Mei Y; Li M; Wen J; Kong X; Li J
Cancer Med; 2023 May; 12(10):12018-12033. PubMed ID: 37017469
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and treatments of patients with alpha-fetoprotein producing gastric carcinoma.
Gong W; Su Y; Liu A; Liu J; Sun D; Jiang T; Xiang J; Chi C; Sun P
Neoplasma; 2018 Mar; 65(3):326-330. PubMed ID: 29788728
[TBL] [Abstract][Full Text] [Related]
14. An analysis of clinical characteristics and prognosis for patients with serum alpha-fetoprotein-positive gastric cancer.
Zuo CT; Ju Q
Minerva Med; 2015 Aug; 106(4):185-91. PubMed ID: 26418320
[TBL] [Abstract][Full Text] [Related]
15. Association of CLDN18 Protein Expression with Clinicopathological Features and Prognosis in Advanced Gastric and Gastroesophageal Junction Adenocarcinomas.
Pellino A; Brignola S; Riello E; Niero M; Murgioni S; Guido M; Nappo F; Businello G; Sbaraglia M; Bergamo F; Spolverato G; Pucciarelli S; Merigliano S; Pilati P; Cavallin F; Realdon S; Farinati F; Dei Tos AP; Zagonel V; Lonardi S; Loupakis F; Fassan M
J Pers Med; 2021 Oct; 11(11):. PubMed ID: 34834447
[TBL] [Abstract][Full Text] [Related]
16. Characteristic analysis of α-fetoprotein-producing gastric carcinoma in China.
Li XD; Wu CP; Ji M; Wu J; Lu B; Shi HB; Jiang JT
World J Surg Oncol; 2013 Oct; 11():246. PubMed ID: 24083471
[TBL] [Abstract][Full Text] [Related]
17. CLDN18.2 expression and its impact on prognosis and the immune microenvironment in gastric cancer.
Wang C; Wang Y; Chen J; Wang Y; Pang C; Liang C; Yuan L; Ma Y
BMC Gastroenterol; 2023 Aug; 23(1):283. PubMed ID: 37582713
[TBL] [Abstract][Full Text] [Related]
18. Hepatoid Adenocarcinoma of Stomach: Emphasis on the Clinical Relationship with Alpha-Fetoprotein-Positive Gastric Cancer.
Chen EB; Wei YC; Liu HN; Tang C; Liu ML; Peng K; Liu T
Biomed Res Int; 2019; 2019():6710428. PubMed ID: 31915699
[TBL] [Abstract][Full Text] [Related]
19. Recurrent metastatic patterns and prognosis after radical surgery in patients with alpha-fetoprotein-producing gastric cancer: a retrospective cohort study.
Zhang F; Zhang X; Zhang X; Wang Y; Li T; Guo H; Ding P; Tian Y; Yang P; Li X; Meng N; Guo Z; Zhao Q; Zhang R
Am J Cancer Res; 2024; 14(5):2124-2140. PubMed ID: 38859826
[TBL] [Abstract][Full Text] [Related]
20. Histologic and immunohistochemical analyses of α-fetoprotein--producing cancer of the stomach.
Kinjo T; Taniguchi H; Kushima R; Sekine S; Oda I; Saka M; Gotoda T; Kinjo F; Fujita J; Shimoda T
Am J Surg Pathol; 2012 Jan; 36(1):56-65. PubMed ID: 22173117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
